...
首页> 外文期刊>Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association >Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.
【24h】

Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome.

机译:嘌呤霉素氨基核苷酸引起的肾病综合征的肾脏多巴胺能系统活动减弱。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: A primary tubular sodium handling abnormality has been implicated in the edema formation of nephrotic syndrome. Dopamine synthesized by renal proximal tubules behaves as an endogenous natriuretic hormone by activating D(1)-like receptors as a paracrine/autocrine substance. METHODS: We examined the time courses of the urinary excretion of sodium, protein and dopamine in puromycin aminonucleoside (PAN)-treated and control rats. The rats were sacrificed during greatest sodium retention (day 7) as well as during negative sodium balance (day 14) for the evaluation of renal aromatic l-amino acid decarboxylase (AADC) activity, the enzyme responsible for the synthesis of renal dopamine. Also, the influence of volume expansion (VE) and the effects of the D(1)-like agonist fenoldopam (10 microg/kg bw/min) on natriuresis and on proximal tubular Na(+),K(+)-ATPase activity were examined on day 7. RESULTS: The daily urinary excretion of dopamine was decreased in PAN-treated rats, from day 5 and beyond. This was accompanied by a marked decrease in the renal AADC activity, on days 7 and 14. During VE, the fenoldopam-induced decrease in proximal tubular Na(+),K(+)-ATPase activity was more pronounced in PAN-treated rats than in controls. However, the urinary sodium excretion during fenoldopam infusion was markedly increased in control rats but was not altered in PAN-treated animals. CONCLUSION: PAN nephrosis is associated with a blunted renal dopaminergic system activity which may contribute to enhance the proximal tubular Na(+),K(+)-ATPase activity. However, the lack of renal dopamine appears not to be related with the overall renal sodium retention in a state of proteinuria.
机译:背景:原发性肾小管钠处理异常与肾病综合征的水肿形成有关。肾近端小管合成的多巴胺通过激活D(1)-样受体作为旁分泌/自分泌物质而表现为内源性利钠激素。方法:我们检查了嘌呤霉素氨基核苷(PAN)治疗和对照组大鼠尿钠,蛋白质和多巴胺排泄的时间过程。在最大的钠retention留期间(第7天)以及在钠负平衡期间(第14天)处死大鼠,以评估肾芳香族1-氨基酸脱羧酶(AADC)活性,所述酶是负责肾脏多巴胺合成的酶。此外,体积膨胀(VE)的影响和D(1)样激动剂非诺多m(10 microg / kg bw / min)对利尿和近端肾小管Na(+),K(+)-ATPase活性的影响在第7天进行了检查。结果:从PAN处理的第5天开始,每天的多巴胺尿排泄量都减少了。在第7天和第14天,这伴随着肾脏AADC活性的明显降低。在VE期间,在用PAN治疗的大鼠中,非诺多巴诱导的近端肾小管Na(+),K(+)-ATPase活性降低更为明显。比在控件中。但是,在非诺多m输注过程中,对照组大鼠的尿钠排泄显着增加,但在PAN处理的动物中并未改变。结论:PAN肾病与肾脏多巴胺能系统钝化有关,可能有助于增强近端肾小管Na(+),K(+)-ATPase活性。但是,肾多巴胺的缺乏似乎与蛋白尿状态的总体肾钠retention留无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号